Cargando…
The Role of Non-Coding RNAs in the Sorafenib Resistance of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death. Sorafenib is approved by the U.S. Food and Drug Administration to be a first-line chemotherapy agent for patients with advanced HCC. A portion of advanced HCC patients can benefit from the treatment with sorafeni...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340683/ https://www.ncbi.nlm.nih.gov/pubmed/34367979 http://dx.doi.org/10.3389/fonc.2021.696705 |